πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12325705

Small molecules for the treatment of primary cancer and cancer metastasis

The Board of Regents of the University of Texas System Β· Granted Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12325747

Human PD-L1 antibodies and methods of use therefor

The Board of Regents of the University of Texas System Β· Granted Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12325691

Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anx

The Board of Regents of the University of Texas System Β· Granted Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12319744

Treatment and prevention of hemophilic arthropathy with an antibody against endothelial ce

The Board of Regents of the University of Texas System Β· Granted Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12318439

Attenuating viral mutations in protein genes

The Board of Regents of the University of Texas System Β· Granted Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12319708

Agonists of peroxisome proliferator-activated receptor alpha (PPARΞ±) and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12319740

Methods for production of tissue resident memory-like T cells and use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12318413

Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome

The Board of Regents of the University of Texas System Β· Granted Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12312589

RNA-nanostructured double robots and methods of use thereof

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12310988

BCMA chimeric antigen receptors and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12310986

Compositions and methods for the treatment of cancer cells by induction of cytotoxic oxida

The Board of Regents of the University of Texas System Β· Granted Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12311030

Antibody-sting agonist conjugates and their use in immunotherapy

The Board of Regents of the University of Texas System Β· Granted Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12310996

Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome

The Board of Regents of the University of Texas System Β· Granted Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12312334

Quinoxaline compounds and uses thereof

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12304930

Prefusion-stabilized hMPV F proteins

The Board of Regents of the University of Texas System Β· Granted Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12303594

Antimicrobial and anti-inflammatory compositions

The Board of Regents of the University of Texas System Β· Granted Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12297447

Gene therapy for juvenile Batten disease

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12297259

Aspergillus antigen chimeric receptors and use thereof

The Board of Regents of the University of Texas System Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12296066

Methods of wound healing with Serp-1 polypeptides

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12286406

Inhibitors of receptor interacting protein kinase I for the treatment of disease

The Board of Regents of the University of Texas System Β· Granted Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12280088

Dry powder formulation of caveolin-1 peptides and methods of use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12280057

Vasoactive topical compound to affect tissue blood flow, reduce tissue necrosis and promot

SOUTH DAKOTA BOARD OF REGENTS Β· Granted Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12280089

Dry powder formulation of caveolin-1 peptides and methods of use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12281078

Quinoline cGAS antagonist compounds

The Board of Regents of the University of Texas System Β· Granted Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted